The BioMed Alliance has joined 18 EU-level health organisations who have come together to ensure that the needs of patients are prioritised during the Brexit negotiations. This event will explore what pragmatic steps can be taken by EU decision-makers to ensure patients and public health are not forgotten during the Article 50 negotiations, regardless of how the talks progress. It will consider what can be done to ensure public health and health security are prioritised during those talks.

Confirmed speakers include:

  • Prof. Gerd R. Burmester - Professor of Medicine in the Department of Rheumatology and Clinical Immunology at the Charité University Hospital, Free University and Humboldt University of Berlin, Germany
  • Dr Gabriel Siles-Brügge - Associate Professor in Public Policy and the Programme Director for the MA in Public Policy
  • Yvonne Stewart - Head of Brexit Implementation at GlaxoSmithKline
  • Prof. Stafford Lightman - Professor of Medicine at the University of Bristol and Director of the Henry Wellcome Laboratories for Integrative Neuroscience and Endocrinology
  • Prof. Wilfried Ellmeier - Professor of Immunobiology at the Institute of Immunology, Medical University of Vienna
  • Derick Mitchell - Chief Executive of The Irish Platform for Patient Organisations, Science and Industry
  • Adina-Ioana Vălean MEP - Chair of the Committee on the Environment, Public Health and Food Safety

brexit

Registration

The event will take place on 27 September 9.00 – 11.00 am, Room 4Q2, European Parliament. If you would like to attend, please register your details by 20 September.

We use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies.